Corradini Paolo

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma / R.W. Merryman, L. Castagna, L. Giordano, V.T. Ho, P. Corradini, A. Guidetti, B. Casadei, D.A. Bond, S. Jaglowski, M.A. Spinner, S. Arai, R. Lowsky, G.L. Shah, M.-. Perales, J.M.S. De Colella, D. Blaise, A.F. Herrera, G. Shouse, C. Spilleboudt, S.M. Ansell, Y. Nieto, T. Badar, M. Hamadani, T.A. Feldman, L. Dahncke, A.K. Singh, J.P. McGuirk, T. Nishihori, J. Chavez, A.V. Serritella, J. Kline, M. Mohty, R. Dulery, A. Stamatoulas, R. Houot, G. Manson, M.-. Moles-Moreau, C. Orvain, K. Bouabdallah, D. Modi, R. Ramchandren, L. Lekakis, A. Beitinjaneh, M.J. Frigault, Y.-. Chen, R.C. Lynch, S.D. Smith, U. Rao, M. Byrne, J.T. Romancik, J.B. Cohen, S. Nathan, T. Phillips, R.M. Joyce, M. Rahimian, A. Bashey, H.J. Ballard, J. Svoboda, V. Torri, M. Sollini, C. De Philippis, M. Magagnoli, A. Santoro, P. Armand, P.L. Zinzani, C. Carlo-Stella. - In: LEUKEMIA. - ISSN 0887-6924. - (2021 May 03). [Epub ahead of print]

A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) / C. Boccomini, M. Ladetto, L. Rigacci, B. Puccini, S. Rattotti, S. Volpetti, S. Ferrero, A. Chiarenza, R. Freilone, M. Novo, P. Corradini, L. Nassi, C. Rusconi, C. Stelitano, S. Bolis, A. Marina Liberati, A. Tucci, L. Baldini, M. Balzarotti, A. Evangelista, G. Ciccone, U. Vitolo. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - (2021). [Epub ahead of print]

Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors : a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) / M. Breccia, S. Celant, P.P. Olimpieri, O.M. Olimpieri, F. Pane, A. Iurlo, A. Cirilli, A. Colatrella, L. Gozzo, S. Pugliese, V. Summa, P. Foggi, P. Corradini, P. Russo, G. Bartoccioni, D. Ricagni, S. Di Segni, S. Valentini, V. Angelini, P. D'Antrassi, P. Lido. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 100:2(2021), pp. 481-485.

Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas / L. Castagna, A. Dodero, F. Patriarca, F. Onida, A. Olivieri, D. Russo, L. Giordano, I. Majolino, S. Bramanti, J. Mariotti, B. Sarina, C. De Philippis, L. Farina, C. Carlo-Stella, P. Corradini, A. Santoro. - In: TRANSPLANTATION AND CELLULAR THERAPY. - ISSN 2666-6367. - 27:4(2021), pp. 328e1-328.e6.

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma / M. Balzarotti, M. Magagnoli, M.A. Canales, P. Corradini, C. Grande, J.-. Sancho, F. Zaja, A.-. Quinson, V. Belsack, D. Maier, C. Carlo-Stella. - In: INVESTIGATIONAL NEW DRUGS. - ISSN 0167-6997. - (2021). [Epub ahead of print]